CAR-T cell therapy followed by allogenic hematopoietic stem cell transplantation yielded comparable outcome between Ph like ALL and other high-risk ALL

It was previously believed that patients with Ph-like ALL had poorer prognosis compared with other B-ALL subgroups due to resistance to conventional chemotherapy and lack of targeted drugs. CAR-T therapy has been successfully applied in the treatment of relapsed and refractory B-ALL. Currently, ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Hai-ping, Kong, Dan-qing, Shen, Hong-jie, Cui, Wei, Wang, Qian, Li, Zheng, Yin, Jia, Kang, Li-qing, Yu, Lei, Wu, De-pei, Tang, Xiao-wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930301/
https://www.ncbi.nlm.nih.gov/pubmed/36793095
http://dx.doi.org/10.1186/s40364-023-00451-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930301/
https://www.ncbi.nlm.nih.gov/pubmed/36793095
http://dx.doi.org/10.1186/s40364-023-00451-2

Ejemplares similares